grepcent public filings, reorganized for comparison

Analysis reports

Largest positive accrual gap (net income minus operating cash flow, scaled by average assets)

Companies ranked mechanically by (net income minus operating cash flow) divided by average total assets, all for the same latest fiscal year (average of that year-end and the prior year-end), from SEC companyfacts. Rows require average assets of at least $100.0M and exclude SIC 6xxx financial companies.

Descriptive ranking — not investment advice. Mechanical ranking by stated metric from SEC/FRED data; not a recommendation, endorsement, or investment judgment. As of: 2026-09-18. See Disclaimer.

Chart

Largest positive accrual gap (net income minus operating cash flow, scaled by average assets). Source: grepcent computed analysis from site-data.json.Largest positive accrual gap (net income minus operating cash flow, scaled by average assets). Source: grepcent computed analysis from site-data.json.Largest positive accrual gap (net income minus operating cash flow, scaled by average assets)Highest displayed value: ABEO = 89.81%Source: grepcent computed analysis from site-data.json.Accrual gap (%)Accrual gap0.0%50.0%100.0%ABEOCHRSRIGLSEATARENTGTXBYNDSPIRHUMANVAXSMCIWDCOMERZVRAALMSSRTASKYTMASSPSIXSAFXAUPHLYFTVISNARVNATEXAMSCDDDDJCOSATLBEAMACADFTAIINDVADMAAAOIWNCNTNXSABRSOUNPLUSBYDKMTFTKCYRXXOMANSPRCUSUNITNVDAALEC

Table

RankCompanyAccrual gapFYPeriod endComparabilityRegimeExtra
1ABEO - ABEONA THERAPEUTICS INC.89.81%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (71,183,000 USD) exceeded revenue (5,820,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operatingNI minus OCF $147.5M; avg assets $164.3M
2CHRS - Coherus Oncology, Inc.86.73%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (168,024,000 USD) exceeded revenue (42,172,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operatingNI minus OCF $306.5M; avg assets $353.4M
3RIGL - RIGEL PHARMACEUTICALS INC86.00%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (367,024,000 USD) exceeded revenue (294,282,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operatingNI minus OCF $291.4M; avg assets $338.8M
4SEAT - Vivid Seats Inc.78.99%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (806,054,000 USD) exceeded revenue (450,509,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operatingNI minus OCF $897.7M; avg assets $1.1B
5AREN - Arena Group Holdings, Inc.74.79%2025as of 2025-12-310d (aligned)operatingNI minus OCF $85.6M; avg assets $114.5M
6TGTX - TG THERAPEUTICS, INC.57.52%2025as of 2025-12-310d (aligned)operatingNI minus OCF $472.0M; avg assets $820.5M
7BYND - BEYOND MEAT, INC.56.30%2025as of 2025-12-310d (aligned)operatingNI minus OCF $364.0M; avg assets $646.4M
8SPIR - Spire Global, Inc.54.94%2025as of 2025-12-310d (aligned)operatingNI minus OCF $111.1M; avg assets $202.3M
9HUMA - Humacyte, Inc.50.51%2025as of 2025-12-310d (aligned)operatingNI minus OCF $64.2M; avg assets $127.1M
10NVAX - NOVAVAX INC50.05%2025as of 2025-12-310d (aligned)operatingNI minus OCF $684.9M; avg assets $1.4B
11SMCI - Super Micro Computer, Inc.41.13%2026as of 2026-06-30about 6 months after row reference (+181d) (offset)operatingNI minus OCF $9.0B; avg assets $22.0B
12WDC - WESTERN DIGITAL CORP39.44%2026as of 2026-07-03about 6 months after row reference (+184d) (offset)operatingNI minus OCF $5.5B; avg assets $13.9B
13OMER - OMEROS CORP37.41%2025as of 2025-12-310d (aligned)operatingNI minus OCF $112.7M; avg assets $301.4M
14ZVRA - ZEVRA THERAPEUTICS, INC.36.65%2025as of 2025-12-310d (aligned)operatingNI minus OCF $84.8M; avg assets $231.4M
15ALMS - ALUMIS INC.33.52%2025as of 2025-12-310d (aligned)operatingNI minus OCF $126.2M; avg assets $376.5M
16SRTA - Strata Critical Medical, Inc.31.01%2025as of 2025-12-310d (aligned)operatingNI minus OCF $90.3M; avg assets $291.1M
17SKYT - SkyWater Technology, LLC28.28%2025as of 2025-12-28-3d (aligned)operatingNI minus OCF $147.9M; avg assets $522.9M
18MASS - 908 Devices Inc.24.70%2025as of 2025-12-310d (aligned)operatingNI minus OCF $43.2M; avg assets $174.8M
19PSIX - POWER SOLUTIONS INTERNATIONAL, INC.23.87%2025as of 2025-12-310d (aligned)operatingNI minus OCF $89.9M; avg assets $376.5M
20SAFX - XCF Global, Inc.23.73%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (74,004,768 USD) exceeded revenue (20,815,955 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operatingNI minus OCF $91.9M; avg assets $387.1M
21AUPH - Aurinia Pharmaceuticals Inc.23.27%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (287,202,000 USD) exceeded revenue (283,055,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operatingNI minus OCF $151.5M; avg assets $651.1M
22LYFT - Lyft, Inc.23.17%2025as of 2025-12-310d (aligned)operatingNI minus OCF $1.7B; avg assets $7.2B
23VISN - Vistance Networks, Inc.21.64%2025as of 2025-12-310d (aligned)
Data-quality note. FY2025 net income (2,283,700,000 USD) exceeded revenue (1,931,600,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operatingNI minus OCF $2.0B; avg assets $9.1B
24ARVN - ARVINAS, INC.21.33%2025as of 2025-12-310d (aligned)operatingNI minus OCF $193.0M; avg assets $904.6M
25ATEX - Anterix Inc.21.33%2026as of 2026-03-31about 3 months after row reference (+90d) (offset)
Data-quality note. FY2026 net income (90,635,000 USD) exceeded revenue (6,501,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operatingNI minus OCF $85.1M; avg assets $399.2M
26AMSC - AMERICAN SUPERCONDUCTOR CORP /DE/21.08%2026as of 2026-03-31about 3 months after row reference (+90d) (offset)operatingNI minus OCF $110.7M; avg assets $525.0M
27DDD - 3D SYSTEMS CORP20.82%2025as of 2025-12-310d (aligned)operatingNI minus OCF $117.7M; avg assets $565.3M
28DJCO - DAILY JOURNAL CORP20.76%2025as of 2025-09-30about 3 months before row reference (-92d) (offset)
Data-quality note. FY2025 net income (112,137,000 USD) exceeded revenue (87,700,000 USD). This uncommon relationship can occur when large non-operating items, including investment or securities gains, asset or voucher sales, or tax benefits, contribute to net income. The relationship alone is not evidence of an extraction error; grepcent shows both figures as filed and does not infer the company-specific cause from these XBRL facts.
operatingNI minus OCF $98.8M; avg assets $475.9M
29SATL - Satellogic Inc.20.75%2025as of 2025-12-310d (aligned)operatingNI minus OCF $22.1M; avg assets $106.5M
30BEAM - Beam Therapeutics Inc.20.51%2025as of 2025-12-310d (aligned)operatingNI minus OCF $265.1M; avg assets $1.3B
31ACAD - ACADIA PHARMACEUTICALS INC20.43%2025as of 2025-12-310d (aligned)operatingNI minus OCF $281.2M; avg assets $1.4B
32FTAI - FTAI Aviation Ltd.19.30%2025as of 2025-12-310d (aligned)operatingNI minus OCF $811.8M; avg assets $4.2B
33INDV - Indivior Pharmaceuticals, Inc.18.83%2025as of 2025-12-310d (aligned)operatingNI minus OCF $237.0M; avg assets $1.3B
34ADMA - ADMA BIOLOGICS, INC.17.35%2025as of 2025-12-310d (aligned)operatingNI minus OCF $96.5M; avg assets $556.5M
35AAOI - APPLIED OPTOELECTRONICS, INC.15.88%2025as of 2025-12-310d (aligned)operatingNI minus OCF $136.2M; avg assets $857.7M
36WNC - WABASH NATIONAL Corp15.47%2025as of 2025-12-310d (aligned)operatingNI minus OCF $199.8M; avg assets $1.3B
37NTNX - Nutanix, Inc.14.12%2026as of 2026-07-31about 7 months after row reference (+212d) (offset)operatingNI minus OCF $590.1M; avg assets $4.2B
38SABR - Sabre Corp13.87%2025as of 2025-12-310d (aligned)operatingNI minus OCF $633.5M; avg assets $4.6B
39SOUN - SOUNDHOUND AI, INC.13.56%2025as of 2025-12-310d (aligned)operatingNI minus OCF $84.2M; avg assets $621.1M
40PLUS - EPLUS INC13.53%2026as of 2026-03-31about 3 months after row reference (+90d) (offset)operatingNI minus OCF $248.9M; avg assets $1.8B
41BYD - BOYD GAMING CORP13.37%2025as of 2025-12-310d (aligned)operatingNI minus OCF $866.6M; avg assets $6.5B
42KMT - KENNAMETAL INC12.13%2026as of 2026-06-30about 6 months after row reference (+181d) (offset)operatingNI minus OCF $346.4M; avg assets $2.9B
43FTK - FLOTEK INDUSTRIES INC/CN/11.94%2025as of 2025-12-310d (aligned)operatingNI minus OCF $23.3M; avg assets $195.4M
44CYRX - Cryoport, Inc.11.83%2025as of 2025-12-310d (aligned)operatingNI minus OCF $86.9M; avg assets $734.2M
45XOMA - XOMA Royalty Corp11.68%2025as of 2025-12-310d (aligned)operatingNI minus OCF $28.8M; avg assets $247.0M
46NSP - INSPERITY, INC.11.29%2025as of 2025-12-310d (aligned)operatingNI minus OCF $271.0M; avg assets $2.4B
47RCUS - Arcus Biosciences, Inc.11.27%2025as of 2025-12-310d (aligned)operatingNI minus OCF $129.0M; avg assets $1.1B
48UNIT - Uniti Group Inc.11.02%2025as of 2025-12-310d (aligned)operatingNI minus OCF $954.5M; avg assets $8.7B
49NVDA - NVIDIA CORP10.90%2026as of 2026-01-25+25d (offset)operatingNI minus OCF $17.3B; avg assets $159.2B
50ALEC - Alector, Inc.10.79%2025as of 2025-12-310d (aligned)operatingNI minus OCF $41.1M; avg assets $380.8M